This site uses cookies to store information on your computer. Learn more x

                                        Consensus Figures

                                        A number of international financial analysts cover DSM. The most recent consensus figures – provided by Vara Research – are detailed below. The figures are based on the estimates given by the analysts that were approached by Vara Research.  

                                        Analysts’ consensus Q2 2019 and FY 2019 as at 5 July 2019

                                          Q2 2018 FY 2018 Q2 2019 E* FY 2019 E*
                                        Sales (continuing)        
                                        Number of Estimates     15 15
                                        Highest     2,371 9,518
                                        Consensus 2,359 9,267 2,307 9,297
                                        Median     2,309 9,303
                                        Lowest     2,275 9,159
                                        adj. EBITDA (continuing)        
                                        Number of Estimates     15 15
                                        Highest     446 1,767
                                        Consensus 508 1,822 429 1,704
                                        Median     432 1,704
                                        Lowest     393 1,666
                                        of which estimated adj. EBITDA from"Temporary Vitamin Effect"        
                                        Number of Estimates     0 0
                                        Highest     0 0
                                        Consensus 110 290 0 0
                                        Median     0 0
                                        Lowest     0 0
                                        Underlying business,  adj. EBITDA        
                                        Number of Estimates     15 15
                                        Highest     446 1,767
                                        Consensus 398 1,532 429 1,704
                                        Median     432 1,704
                                        Lowest     393 1,666
                                        adj. EBIT (continuing)        
                                        Number of Estimates     13 14
                                        Highest     310 1,202
                                        Consensus 394 1,345 291 1,142
                                        Median     291 1,137
                                        Lowest     273 1,096
                                        Nutrition, Sales        
                                        Number of Estimates     15 15
                                        Highest     1,578 6,362
                                        Consensus 1,555 6,137 1,506 6,134
                                        Median     1,501 6,125
                                        Lowest     1,471 6,024
                                        Nutrition, adj. EBITDA        
                                        Number of Estimates     15 15
                                        Highest     337 1,332
                                        Consensus 397 1,407 319 1,271
                                        Median     319 1,262
                                        Lowest     290 1,243
                                        of which adj. EBITDA from"Temporary Vitamin Effect"        
                                        Number of Estimates     0 0
                                        Highest     0 0
                                        Consensus 110 290 0 0
                                        Median     0 0
                                        Lowest     0 0
                                        Nutrition underlying,  adj. EBITDA        
                                        Number of Estimates     15 15
                                        Highest     337 1,332
                                        Consensus 287 1,117 319 1,271
                                        Median     319 1,262
                                        Lowest     290 1,243
                                        Nutrition, adj. EBIT        
                                        Number of Estimates     13 13
                                        Highest     254 992
                                        Consensus 328 1,111 235 922
                                        Median     231 913
                                        Lowest     218 885
                                        Materials, Sales        
                                        Number of Estimates     15 15
                                        Highest     783 2,983
                                        Consensus 754 2,913 744 2,924
                                        Median     743 2,922
                                        Lowest     724 2,841
                                        Materials, adj. EBITDA        
                                        Number of Estimates     15 15
                                        Highest     136 549
                                        Consensus 135 512 131 516
                                        Median     131 517
                                        Lowest     123 496
                                        Materials, adj. EBIT        
                                        Number of Estimates     13 13
                                        Highest     102 413
                                        Consensus 104 383 96 380
                                        Median     98 383
                                        Lowest     87 329
                                        Innovation Center, Sales        
                                        Number of Estimates     15 15
                                        Highest     49 214
                                        Consensus 39 172 45 191
                                        Median     45 188
                                        Lowest     39 179
                                        Innovation Center, adj. EBITDA        
                                        Number of Estimates     15 15
                                        Highest     6 24
                                        Consensus 1 8 4 19
                                        Median     5 21
                                        Lowest     1 9
                                        Innovation Center, adj. EBIT        
                                        Number of Estimates     13 13
                                        Highest     0 -1
                                        Consensus -6 -14 -2 -8
                                        Median     -2 -7
                                        Lowest     -6 -23
                                        Corporate Activities, Sales        
                                        Number of Estimates     15 15
                                        Highest     20 71
                                        Consensus 11 45 12 49
                                        Median     11 45
                                        Lowest     10 45
                                        Corporate Activities, adj. EBITDA        
                                        Number of Estimates     15 15
                                        Highest     -23 -95
                                        Consensus -25 -105 -26 -102
                                        Median     -25 -100
                                        Lowest     -27 -110
                                        Corporate Activities, adj. EBIT        
                                        Number of Estimates     13 13
                                        Highest     -33 -135
                                        Consensus -32 -135 -38 -152
                                        Median     -37 -152
                                        Lowest     -43 -171
                                        Profit for the period, before exceptional items - Cont. Ops.        
                                        Number of Estimates     15 15
                                        Highest     241 913
                                        Consensus 306 1,034 214 844
                                        Median     217 839
                                        Lowest     192 795
                                        Net EPS before exceptional items - Cont. Ops.        
                                        Number of Estimates     15 15
                                        Highest     1.37 5.34
                                        Consensus 1.73 5.84 1.22 4.88
                                        Median     1.23 4.87
                                        Lowest     1.08 4.52

                                        * Analysts were asked by Vara Research to include the estimated IFRS16 effect in the DSM consensus poll for 2019 Q2 and FY 2019.
                                         

                                        Disclaimer
                                        Consensus earnings estimates are based on earnings projections made by securities analysts who cover DSM. Any opinions, forecasts, estimates, projections or predictions regarding DSM’s performance made by the analysts (and, therefore, the Consensus estimate numbers) are theirs alone and do not represent the opinions, forecasts, estimates, projections or predictions of DSM or its management. DSM does not by providing these estimates imply its endorsement of or concurrence with such information, conclusions or recommendations. DSM assumes no liability for the accuracy of such estimates and undertakes no obligation to update or revise such estimates.

                                        吉林快三开奖走势图 国际足联排名积分规则 好运快3怎么玩 体彩p3出号分析图 北京时时彩赛车违法吗 云南快乐10分开将结果组三 金沙娱乐场骰宝打不开 特区七星彩票论坛 扑克牌升级 广西快乐双彩最新开奖结果查询结果 北京pk10实时开奖记录 安徽快3二同最大遗漏 北京赛车pk10彩票控 pk10专家预测 排球主场论坛 六肖中特免费